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Background
MEC/CCL28 (CCL28) binds to CCR3 and CCR10 and
recruits IgA-secreting plasma cells (IgA-ASCs) in the
mucosal lamina propria. Virus-like Particles (VLPs) are
a novel vaccine approach based on non-pathogenic par-
ticles that mimic the structure of virus particles with
effective induction of both arms of the immune
response. The suitability of CCL28 as an adjuvant for
the elicitation of optimal mucosal and systemic immu-
nity was assessed in mice immunized with HIV-1 VLPs.
Methods
Balb/c mice were immunized intramuscularly with a
prime-boost regime based on VLP containing gp160
from HIV-1 IIIB in the presence/absence of CCL28 and
of the parental control CCL19. Flow citometry evalua-
tion of CCR3 and CCR10 expression was performed on
purified splenocytes. Th1 and Th2 cytokine production
was performed on splenocytes and either colon, lungs or
uterine cervix, whereas antigen-specific IgG and IgA
antibodies were evaluated in sera and mucosal secre-
tions by ELISA. Immune sera and mucosal secretions
were tested for ex vivo neutralization activity against
HIV-1 either subtype B or C strains. IgA-ASC recruit-
ment at the mucosal level was verified with immune-
histochemistry.
Results
The following parameters were significantly augmented in
VLP-CCL28 mice compared to control groups: the per-
centage and the surface density of CCR3 and CCR10 on
CD19+ splenocytes; IFN-g, IL-4 and IL-5 production in
splenocytes and mucosal specimens; total IgA titers in sera
and in mucosal secretions; antigen-specific IgG and IgA
titers in sera and in mucosal secretions. Sera and mucosal
secretions from VLP-CCL28 mice showed a significantly
augmented neutralizing activity against homologous and
heterologous viruses. IgA-ASCs were significantly
increased in mucosal tissues of VLP-CCL28 mice.
Conclusion
CCL28 used as an adjuvant has a robust immunomodu-
latory effect on potentially beneficial mucosal and sys-
temic immune responses. These findings suggest that
CCL28 could play a useful role in increasing the efficacy
of preventive vaccines for mucosally transmitted viral
infections.
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